AI Drug Development Stocks Rally Early in Trading, METIS TECHBIO-P Jumps Over 13%, INWISEAI Up More Than 11%

Deep News
8小时前

Shares of companies focused on AI-driven pharmaceutical development experienced a broad uptick during the morning session, with several key players posting significant gains.

At the time of reporting, METIS TECHBIO-P (07666) surged by 13.20%, trading at HK$17.58, while INWISEAI (03696) climbed 10.98% to HK$59.65. Meanwhile, XtalPi Holdings (02228) advanced 8.34% to HK$7.47, and GenScript Biotech (01548) rose 6.39% to HK$39.60.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10